Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

References for PMC Articles for PubMed (Select 22936894)

1.

Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function.

Marina AL, Utzschneider KM, Wright LA, Montgomery BK, Marcovina SM, Kahn SE.

Diabetes Care. 2012 May;35(5):1119-25. doi: 10.2337/dc11-2050. Epub 2012 Mar 23.

2.

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

Beysen C, Murphy EJ, Deines K, Chan M, Tsang E, Glass A, Turner SM, Protasio J, Riiff T, Hellerstein MK.

Diabetologia. 2012 Feb;55(2):432-42. doi: 10.1007/s00125-011-2382-3. Epub 2011 Dec 2.

PMID:
22134839
3.

Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

Kawashiri MA, Nohara A, Noguchi T, Tada H, Nakanishi C, Mori M, Konno T, Hayashi K, Fujino N, Inazu A, Kobayashi J, Mabuchi H, Yamagishi M.

Am J Cardiol. 2012 Feb 1;109(3):364-9. doi: 10.1016/j.amjcard.2011.09.019. Epub 2011 Nov 22.

PMID:
22112743
4.

Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.

Henry RR, Aroda VR, Mudaliar S, Garvey WT, Chou HS, Jones MR.

Diabetes Obes Metab. 2012 Jan;14(1):40-6. doi: 10.1111/j.1463-1326.2011.01486.x. Epub 2011 Nov 21.

PMID:
21831167
5.

Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.

Vega GL, Dunn FL, Grundy SM.

Am J Cardiol. 2011 Oct 15;108(8):1129-35. doi: 10.1016/j.amjcard.2011.06.011. Epub 2011 Aug 1.

PMID:
21813109
6.

Liver receptor homolog-1 is critical for adequate up-regulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration.

Out C, Hageman J, Bloks VW, Gerrits H, Sollewijn Gelpke MD, Bos T, Havinga R, Smit MJ, Kuipers F, Groen AK.

Hepatology. 2011 Jun;53(6):2075-85. doi: 10.1002/hep.24286.

PMID:
21391220
7.

Add-on therapy for hypercholesterolemia: a pilot comparison of two gastrointestinally-acting agents in statin-treated patients.

Zema MJ.

J Clin Lipidol. 2009 Apr;3(2):119-24. doi: 10.1016/j.jacl.2009.02.008. Epub 2009 Feb 11.

PMID:
21291801
8.

Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels.

Davidson MH.

J Clin Lipidol. 2008 Apr;2(2):S29-33. doi: 10.1016/j.jacl.2008.01.009.

PMID:
21291718
9.

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.

Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH.

J Clin Lipidol. 2007 Dec;1(6):626-33. doi: 10.1016/j.jacl.2007.10.004. Epub 2007 Oct 18.

PMID:
21291705
10.

Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease.

Moore A, Phan BA, Challender C, Williamson J, Marcovina S, Zhao XQ.

J Clin Lipidol. 2007 Dec;1(6):620-5. doi: 10.1016/j.jacl.2007.09.001. Epub 2007 Sep 15.

PMID:
21291704
11.

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism.

Brufau G, Stellaard F, Prado K, Bloks VW, Jonkers E, Boverhof R, Kuipers F, Murphy EJ.

Hepatology. 2010 Oct;52(4):1455-64. doi: 10.1002/hep.23831.

PMID:
20725912
12.

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.

Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL.

Endocr Pract. 2010 Jul-Aug;16(4):617-28. doi: 10.4158/EP10129.OR.

PMID:
20634176
13.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
14.

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.

Chen L, McNulty J, Anderson D, Liu Y, Nystrom C, Bullard S, Collins J, Handlon AL, Klein R, Grimes A, Murray D, Brown R, Krull D, Benson B, Kleymenova E, Remlinger K, Young A, Yao X.

J Pharmacol Exp Ther. 2010 Jul;334(1):164-70. doi: 10.1124/jpet.110.166892. Epub 2010 Apr 22.

15.

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.

Schwartz SL, Lai YL, Xu J, Abby SL, Misir S, Jones MR, Nagendran S.

Metab Syndr Relat Disord. 2010 Apr;8(2):179-88. doi: 10.1089/met.2009.0049.

PMID:
20059361
16.

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

Shang Q, Saumoy M, Holst JJ, Salen G, Xu G.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G419-24. doi: 10.1152/ajpgi.00362.2009. Epub 2009 Dec 31.

17.

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M.

N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15.

18.

Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.

Staels B, Fonseca VA.

Diabetes Care. 2009 Nov;32 Suppl 2:S237-45. doi: 10.2337/dc09-S355. Review. No abstract available.

19.

Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion.

Beglinger S, Drewe J, Schirra J, Göke B, D'Amato M, Beglinger C.

J Clin Endocrinol Metab. 2010 Feb;95(2):879-86. doi: 10.1210/jc.2009-1062. Epub 2009 Oct 16.

PMID:
19837920
20.

Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide.

Brown KS, Armstrong IC, Wang A, Walker JR, Noveck RJ, Swearingen D, Allison M, Kissling JC, Kisicki J, Salazar DE.

J Clin Pharmacol. 2010 May;50(5):554-65. doi: 10.1177/0091270009349378. Epub 2009 Sep 29.

PMID:
19789374
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk